Browsing by Author Lam, David Chi-Leung
Showing results 1 to 2 of 2
Issue Date | Title | Author(s) |
May-2021 | Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations | Chang, Gee-Chen; Lam, David Chi-Leung; Tsai, Chun-Ming; Chen, Yuh-Min; Shih, Jin-Yuan; Aggarwal, Shyam; Wang, Shuhang; Kim, Sang-We; Kim, Young-Chul; Wahid, Ibrahim; Li, Rubi; Lim, Darren Wan-Teck; Sriuranpong, Virote; Chan, Raymond Tsz-Tong; Lorence, Robert M.; Carriere, Philippe; Raabe, Christina; Cseh, Agnieszka; Park, Keunchil |
Jan-2022 | A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naive Patients with EGFRm plus NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China | Tu, Hai-Yan; Feng, Jifeng; Shi, Meiqi; Zhao, Jun; Wang, Yuyan; Chang, Jianhua; Wang, Jialei; Cheng, Ying; Zhu, Jing; Tan, Eng-Huat; Li, Kai; Zhang, Yiping; Lee, Victor; Yang, Cheng-Ta; Su, Wu-Chou; Lam, David Chi-Leung; Srinivasa, B. J.; Rajappa, Senthil; Ho, Ching-Liang; Lam, Kwok Chi; Hu, Yi; Bondarde, Shailesh Arjun; Liu, Xiaoqing; Tian, Yahui; Xue, Zhiyi; Cseh, Agnieszka; Huang, Dennis Chin-Lun; Zhou, Caicun; Wu, Yi-Long |